Table of Contents Author Guidelines Submit a Manuscript
HPB Surgery
Volume 2012, Article ID 381328, 8 pages
http://dx.doi.org/10.1155/2012/381328
Research Article

Glycemic Control after Total Pancreatectomy for Intraductal Papillary Mucinous Neoplasm: An Exploratory Study

1Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL 32224, USA
2Division of Endocrinology, Mayo Clinic, Jacksonville, FL 32224, USA
3Department of Surgery, Mayo Clinic, Jacksonville, FL 32224, USA
4Biostatistics Unit, Mayo Clinic, Jacksonville, FL 32224, USA
5Department of Transplantation, Mayo Clinic, Jacksonville, FL 32224, USA

Received 30 April 2012; Accepted 3 July 2012

Academic Editor: Christos G. Dervenis

Copyright © 2012 Laith H. Jamil et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Kiviluoto, T. Schroder, and S. L. Karonen, “Glycemic control and serum lipoproteins after total pancreatectomy,” Annals of Clinical Research, vol. 17, no. 3, pp. 110–115, 1985. View at Google Scholar · View at Scopus
  2. C. M. Dresler, J. G. Fortner, K. McDermott, and D. R. Bajorunas, “Metabolic consequences of (regional) total pancreatectomy,” Annals of Surgery, vol. 214, no. 2, pp. 131–140, 1991. View at Google Scholar · View at Scopus
  3. F. Duron and J. J. Duron, “Pancreatectomy and diabetes,” Annales de Chirurgie, vol. 53, no. 5, pp. 406–411, 1999. View at Google Scholar · View at Scopus
  4. A. Sauvanet, “Functional results of pancreatic surgery,” Revue du Praticien, vol. 52, no. 14, pp. 1572–1575, 2002. View at Google Scholar
  5. B. J. Billings, J. D. Christein, W. S. Harmsen et al., “Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up?” Journal of Gastrointestinal Surgery, vol. 9, no. 8, pp. 1059–1067, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Jethwa, M. Sodergren, A. Lala et al., “Diabetic control after total pancreatectomy,” Digestive and Liver Disease, vol. 38, no. 6, pp. 415–419, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Kloppel, D. Longnecker, C. Capella, and L. Sobin, Histological Typing of Tumors of the Exocrine Pancreas, World Health Organization International, 2nd edition, 1996.
  8. T. A. Sohn, C. J. Yeo, J. L. Cameron, C. A. Iacobuzio-Donahue, R. H. Hruban, and K. D. Lillemoe, “Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity,” Annals of Surgery, vol. 234, no. 3, pp. 313–322, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Tanaka, S. Chari, V. Adsay et al., “International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas,” Pancreatology, vol. 6, no. 1-2, pp. 17–32, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Bendix Holme, N. O. Jacobsen, M. Rokkjaer, and A. Kruse, “Total pancreatectomy in six patients with intraductal papillary mucinous tumour of the pancreas: the treatment of choice,” Journal of the International Hepato Pancreato Biliary, vol. 3, no. 4, pp. 257–262, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. S. T. Chari, D. Yadav, T. C. Smyrk et al., “Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas,” Gastroenterology, vol. 123, no. 5, pp. 1500–1507, 2002. View at Google Scholar · View at Scopus
  12. T. A. Sohn, C. J. Yeo, J. L. Cameron et al., “Intraductal papillary mucinous neoplasms of the pancreas: an updated experience,” Annals of Surgery, vol. 239, no. 6, pp. 788–799, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Yamaguchi, H. Konomi, K. Kobayashi et al., “Total pancreatectomy for intraductal papillary-mucinous tumor of the pancreas: reappraisal of total pancreatectomy,” Hepato-Gastroenterology, vol. 52, no. 65, pp. 1585–1590, 2005. View at Google Scholar · View at Scopus
  14. A. D. Yang, L. G. Melstrom, D. J. Bentrem et al., “Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience,” Surgery, vol. 142, no. 4, pp. 529–537, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. C. Blanchet, F. Andreelli, J. Y. Scoazec et al., “Total pancreatectomy for mucin-producing tumor of the pancreas,” Annales de Chirurgie, vol. 127, no. 6, pp. 439–448, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. J. A. Shtauffer, J. H. Nguyen, M. G. Heckman et al., “Patient outcomes after total pancreatectomy: a single centre contemporary experience,” Journal of the International Hepato Pancreato Biliary, vol. 11, no. 6, pp. 483–492, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. G. Newcombe, “Interval estimation for the difference between independent proportions: comparison of eleven methods,” Statistics in Medicine, vol. 17, no. 8, pp. 873–890, 1998. View at Google Scholar
  18. F. E. Harrell Jr., Regression Modeling Strategies: With Application to Linear Models, Logistic Regression, and Survival Analysis, 2001.
  19. R. H. Unger, “Glucagon physiology and pathophysiology,” The New England Journal of Medicine, vol. 285, no. 8, pp. 443–449, 1971. View at Google Scholar
  20. H. Karmann, F. Laurent, and P. Mialhe, “Pancreatic hormones disappearance after total pancreatectomy in the duck: correlation between plasma glucagon and glucose,” Hormone and Metabolic Research, vol. 19, no. 11, pp. 538–541, 1987. View at Google Scholar · View at Scopus
  21. N. E. Seymour, C. Brunicardi, R. L. Chaiken et al., “Reversal of abnormal glucose production after pancreatic resection by pancreatic polypeptide administration in man,” Surgery, vol. 104, no. 2, pp. 119–129, 1988. View at Google Scholar · View at Scopus
  22. L. A. Slezak and D. K. Andersen, “Pancreatic resection: effects on glucose metabolism,” World Journal of Surgery, vol. 25, no. 4, pp. 452–460, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Nosadini, S. Del Prato, A. Tiengo et al., “Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes,” Diabetes, vol. 31, no. 4, part 1, pp. 346–355, 1982. View at Google Scholar · View at Scopus
  24. F. P. Gall, C. Gebhardt, and H. Zirngibl, “Chronic pancreatitis, results in 116 consecutive partial duodenopancreatectomies combined with occlusion of the pancreatic duct,” Fortschritte der Medizin, vol. 99, no. 47-48, pp. 1967–1972, 1981. View at Google Scholar · View at Scopus
  25. H. Nathan, C. L. Wolfgang, B. H. Edil et al., “Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective,” Journal of Surgical Oncology, vol. 99, no. 2, pp. 87–92, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Garcea, J. Weaver, J. Phillips et al., “Total pancreatectomy with and without islet cell transplantation for chronic pancreatitis: a series of 85 consecutive patients,” Pancreas, vol. 38, no. 1, pp. 1–7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. D. K. Bartsch, “Familial pancreatic cancer,” British Journal of Surgery, vol. 90, no. 4, pp. 386–387, 2003. View at Google Scholar
  28. S. C. Kim, K. T. Park, Y. J. Lee et al., “Intraductal papillary mucinous neoplasm of the pancreas: clinical characteristics and treatment outcomes of 118 consecutive patients from a single center,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 15, no. 2, pp. 183–188, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. W. Müller, H. Friess, J. Kleeff et al., “Is there still a role for total pancreatectomy?” Annals of Surgery, vol. 246, no. 6, pp. 966–974, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. D. G. Heidt, C. Burant, and D. M. Simeone, “Total pancreatectomy: indications, operative technique, and postoperative sequelae,” Journal of Gastrointestinal Surgery, vol. 11, no. 2, pp. 209–216, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Ohashi, Y. Murakami, and M. Maruyama, “Four cases of mucin producing cancer of the pancreas on specific findings of the papilla of Vater,” Digestive Endoscopy, vol. 20, pp. 348–351, 1982. View at Google Scholar
  32. Y. Itai, K. Ohhashi, and H. Nagai, “‘Ductectatic’ mucinous cystadenoma and cystadenocarcinoma of the pancreas,” Radiology, vol. 161, no. 3, pp. 697–700, 1986. View at Google Scholar · View at Scopus
  33. M. Yamada, S. Kozuka, K. Yamao, S. Nakazawa, Y. Naitoh, and Y. Tsukamoto, “Mucin-producing tumor of the pancreas,” Cancer, vol. 68, no. 1, pp. 159–168, 1991. View at Google Scholar · View at Scopus
  34. K. Yamaguchi, Y. Ogawa, K. Chljiiwa, and M. Tanaka, “Mucin-hypersecreting tumors of the pancreas: assessing the grade of malignancy preoperatively,” American Journal of Surgery, vol. 171, no. 4, pp. 427–431, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. E. V. Loftus Jr., B. A. Olivares-Pakzad, K. P. Batts et al., “Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature,” Gastroenterology, vol. 110, no. 6, pp. 1909–1918, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Sugiyama, Y. Atomi, and J. Hachiya, “Intraductal papillary tumors of the pancreas: evaluation with magnetic resonance cholangiopancreatography,” American Journal of Gastroenterology, vol. 93, no. 2, pp. 156–159, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Salvia, C. Fernández-Del Castillo, C. Bassi et al., “Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection,” Annals of Surgery, vol. 239, no. 5, pp. 678–687, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Kobari, S. I. Egawa, K. Shibuya et al., “Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes. Differences in clinical characteristics and surgical management,” Archives of Surgery, vol. 134, no. 10, pp. 1131–1136, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Terris, P. Ponsot, F. Paye et al., “Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct,” American Journal of Surgical Pathology, vol. 24, no. 10, pp. 1372–1377, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Doi, K. Fujimoto, M. Wada, and M. Imamura, “Surgical management of intraductal papillary mucinous tumor of the pancreas,” Surgery, vol. 132, no. 1, pp. 80–85, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Matsumoto, M. Aramaki, K. Yada et al., “Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas,” Journal of Clinical Gastroenterology, vol. 36, no. 3, pp. 261–265, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. B. S. Choi, T. K. Kim, A. Y. Kim et al., “Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography,” Korean Journal of Radiology, vol. 4, no. 3, pp. 157–162, 2003. View at Google Scholar · View at Scopus
  43. Y. Kitagawa, T. A. Unger, S. Taylor et al., “Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas,” Journal of Gastrointestinal Surgery, vol. 7, no. 1, pp. 12–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Sugiyama, Y. Izumisato, N. Abe, T. Masaki, T. Mori, and Y. Atomi, “Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas,” British Journal of Surgery, vol. 90, no. 10, pp. 1244–1249, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. C. P. Raut, K. R. Cleary, G. A. Staerkel et al., “Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival,” Annals of Surgical Oncology, vol. 13, no. 4, pp. 582–594, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Raimondo, I. Tachibana, R. Urrutia, L. J. Burgart, and E. P. DiMagno, “Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas,” American Journal of Gastroenterology, vol. 97, no. 10, pp. 2553–2558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. D. E. R. Sutherland, A. C. Gruessner, A. M. Carlson et al., “Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes,” Transplantation, vol. 86, no. 12, pp. 1799–1802, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Förster, X. Liu, U. Adam, W. D. Schareck, and U. T. Hopt, “Islet autotransplantation combined with pancreatectomy for treatment of pancreatic adenocarcinoma: a case report,” Transplantation Proceedings, vol. 36, no. 4, pp. 1125–1126, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. F. Alsaif, M. Molinari, A. Al-Masloom, J. R. T. Lakey, T. Kin, and A. M. J. Shapiro, “Pancreatic islet autotransplantation with completion pancreatectomy in the management of uncontrolled pancreatic fistula after whipple resection for ampullary adenocarcinoma,” Pancreas, vol. 32, no. 4, pp. 430–431, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. B. W. Lee, J. H. Jee, J. S. Heo et al., “The favorable outcome of human islet transplantation in Korea: experiences of 10 autologous transplantations,” Transplantation, vol. 79, no. 11, pp. 1568–1574, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Miyakawa, A. Horiguchi, M. Hayakawa et al., “Intraductal papillary adenocarcinoma with mucin hypersecretion and coexistent invasive ductal carcinoma of the pancreas with apparent topographic separation,” Journal of Gastroenterology, vol. 31, no. 6, pp. 889–893, 1996. View at Publisher · View at Google Scholar · View at Scopus
  52. R. P. L. M. Hoogma, P. J. Hammond, R. Gomis et al., “Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial,” Diabetic Medicine, vol. 23, no. 2, pp. 141–147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. D. Bruttomesso, D. Crazzolara, A. Maran et al., “In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine,” Diabetic Medicine, vol. 25, no. 3, pp. 326–332, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group,” The Lancet, vol. 352, no. 9131, pp. 837–853, 1998. View at Publisher · View at Google Scholar · View at Scopus